Size Does Matter!
![](https://eckuity.com/wp-content/uploads/2024/04/Size-matters-1024x937.png)
Commercialization is key to success but the process starts with a deep understanding of the market opportunity.
The One-Handed Economist
![](https://eckuity.com/wp-content/uploads/2023/08/one-handed-economy-new.jpg)
Our views on the economy and where the markets are headed next; which sectors (and sub-sectors) to invest in and which markets to avoid.
Sharpening R&D Focus
![](https://eckuity.com/wp-content/uploads/2023/05/insight-sharpning-randd.jpg)
Where is Big Pharma placing its bets? The upcoming ~$200B patent cliff and the stormy market conditions have significantly increased the pressure on Big Pharma to sustain pipelines while controlling costs. Most of the industry majors slashed their R&D budgets in 2022.
End of an Era
![](https://eckuity.com/wp-content/uploads/2023/03/commentary-end-of-era.jpg)
The era of investing in unproven bets is gone, for the foreseeable future, and only the truly innovative and commercially minded will survive.
Alléger les coûts de la bioproduction
![](https://eckuity.com/wp-content/uploads/2024/03/logo-Pharmaceutiques.jpg)
Reducing the costs of biologic manufacturing. (In french)
Irish America Business 100
![](https://eckuity.com/wp-content/uploads/2022/06/business-100.jpg)
Mark Goldstone is named in 2022s Irish America Business 100.
Investing in a promising early-stage healthcare company.
![](https://eckuity.com/wp-content/uploads/2024/03/investing-promissing.jpg)
Commercialization is key.
This downturn is different.
![](https://eckuity.com/wp-content/uploads/2022/06/bloomberg-radio.jpg)
“We should see a reasonably rapid recovery.”
Healthcare remains robust.
![](https://eckuity.com/wp-content/uploads/2022/06/bloomberg-radio.jpg)
Bloomberg Businessweek. Carol Massar and Tim Stenovec interview Youssef Sebban. May 31, 2022